A new trading day began on Tuesday, with Humana Inc (NYSE: HUM) stock price up 2.57% from the previous day of trading, before settling in for the closing price of $235.39. HUM’s price has ranged from $212.45 to $406.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.65%. Meanwhile, its annual earnings per share averaged 0.87%. With a float of $120.42 million, this company’s outstanding shares have now reached $120.69 million.
Let’s determine the extent of company efficiency that accounts for 65680 employees. In terms of profitability, gross margin is 100.0%, operating margin of 2.78%, and the pretax margin is 1.94%.
Humana Inc (HUM) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of Humana Inc is 0.22%, while institutional ownership is 95.28%. The most recent insider transaction that took place on May 14 ’25, was worth 1,496,984. In this transaction President & CEO of this company bought 6,530 shares at a rate of $229.25, taking the stock ownership to the 30,474 shares. Before that another transaction happened on Apr 08 ’25, when Company’s Former Chief Financial Officer proposed sale 10,959 for $249.31, making the entire transaction worth $2,732,134.
Humana Inc (HUM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.63% during the next five years compared to -13.05% drop over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Here are Humana Inc’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.24. Likewise, its price to free cash flow for the trailing twelve months is 12.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 14.14, a number that is poised to hit 5.90 in the next quarter and is forecasted to reach 14.37 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Looking closely at Humana Inc (NYSE: HUM), its last 5-days average volume was 1.94 million, which is a jump from its year-to-date volume of 1.74 million. As of the previous 9 days, the stock’s Stochastic %D was 80.04%. Additionally, its Average True Range was 8.10.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 31.38%, which indicates a significant decrease from 81.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 17.55% in the past 14 days, which was lower than the 43.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $249.73, while its 200-day Moving Average is $271.04. However, in the short run, Humana Inc’s stock first resistance to watch stands at $246.10. Second resistance stands at $250.75. The third major resistance level sits at $256.58. If the price goes on to break the first support level at $235.62, it is likely to go to the next support level at $229.79. Now, if the price goes above the second support level, the third support stands at $225.14.
Humana Inc (NYSE: HUM) Key Stats
With a market capitalization of 29.14 billion, the company has a total of 120,693K Shares Outstanding. Currently, annual sales are 117,761 M while annual income is 1,207 M. The company’s previous quarter sales were 32,112 M while its latest quarter income was 1,244 M.
